Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SenesTechSNES -1.96%34 6-1 Month Momentum % is -22.33% as of Sep. 08, 2026. GuruFocus rates SNES with a GF Score™ of 34/100 and a GF Value™ of $0.44 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 1,625 Chemicals companies, SenesTech ranks worse than 78.15% on this metric.
6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2026-09-08), SenesTech's 6-1 Month Momentum % is -22.33%.
The industry rank for SenesTech's 6-1 Month Momentum % or its related term are showing as below:
SNES's 6-1 Month Momentum % is ranked worse than 78.15% of 1625
companies
in the Chemicals industry
Industry Median: -2.55
vs SNES: -22.33
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
SenesTech 6-1 Month Momentum % Related Terms
SNES vs CNEY, GLGI, BGLC: 6-1 Month Momentum % Comparison
For the Specialty Chemicals subindustry, SenesTech's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SenesTech 6-1 Month Momentum % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, SenesTech's 6-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where SenesTech's 6-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SenesTech (SNES) has a 6-1 Month Momentum % of -22.33% as of Sep. 08, 2026. 6-1 Month Momentum measures the total return of the stock from 6-month ago to 1-month ago. View historical data on SenesTech and its competitors. According to the industry distribution chart, SenesTech ranks #1270 out of 1625 companies in the Chemicals industry, placing it in the top 78.2%.
Is SenesTech's 6-1 Month Momentum % too high?
SenesTech's current 6-1 Month Momentum % is -22.33%. Based on the distribution chart, SenesTech ranks #1270 out of 1625 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, SenesTech has a GF Score™ of 34/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SenesTech's 6-1 Month Momentum % compare to CNEY and GLGI?
According to the Chemicals industry distribution chart, SenesTech ranks #1270 out of 1625 companies for 6-1 Month Momentum %. This places SenesTech in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 6-1 Month Momentum % for a Chemicals company?
A good 6-1 Month Momentum % depends on the Chemicals industry context. However, 6-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 6-1 Month Momentum % mean?
A high 6-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 6-1 Month Momentum measures the total return of the stock from 6-month ago to 1-month ago. View historical data on SenesTech and its competitors. SenesTech's current 6-1 Month Momentum % is -22.33%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SenesTech stock overvalued right now?
Based on GuruFocus' analysis, SenesTech (SNES) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.44, compared to a current price of $1.01 — trading 129.5% above its estimated fair value. The current 6-1 Month Momentum % is -22.33%. SenesTech's overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 6-1 Month Momentum % calculated?
6-1 Month Momentum % is calculated from a company's financial statements. For SenesTech (SNES), the current 6-1 Month Momentum % is -22.33% as of Sep. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SenesTech (SNES) Overvalued in 2026?
Based on GuruFocus' analysis, SenesTech stock appears to be overvalued.
The current stock price of $1.01 is trading 129.5% above its estimated GF Value™ of $0.44.
GuruFocus considers SenesTech to be Significantly Overvalued.
Key valuation signals for SNES:
6-1 Month Momentum %: -22.33%
GF Value™: $0.44 vs. price of $1.01 (129.5% above fair value)
No single metric tells the full story. See the SNES stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company has developed and are commercializing products for managing animal pest populations through fertility control and population management strategies. Its current products focus on rat and mouse populations, and are known as: ContraPest, Evolve Rat, and Evolve Mouse.
34GF Score
Get the complete analysis for SNES
6-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SNES has been successfully added to your 
